摘要
In most patients with progressive systemic sclerosis (PSS) the oesophagus is affected. Reflux symptoms are most frequent, whilst dysphagia also occurs. Cisapride, a prokinetic agent, may enhance motility along the gastrointestinal tract. The effects of cisapride on oesophageal transit were evaluated in 12 PSS patient using a solid-phase radionuclide oesophageal transit study. Each PSS patient was given cisapride 10 mg or placebo orally three times a day in a random, double-blind, crossover fashion. The results show that cisapride does not seem to have any impact on oesophageal transit in patients with PSS.
原文 | English |
---|---|
頁(從 - 到) | 43-45 |
頁數 | 3 |
期刊 | Clinical Rheumatology |
卷 | 21 |
發行號 | 1 |
DOIs | |
出版狀態 | Published - 2002 |